Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connection

Michael Yaron to Anti-Inflammatory Agents, Non-Steroidal

This is a "connection" page, showing publications Michael Yaron has written about Anti-Inflammatory Agents, Non-Steroidal.

 
Connection Strength
 
 
 
0.261
 
  1. Yaron M, Shirazi I, Yaron I. Anti-interleukin-1 effects of diacerein and rhein in human osteoarthritic synovial tissue and cartilage cultures. Osteoarthritis Cartilage. 1999 May; 7(3):272-80.
    View in: PubMed
    Score: 0.125
  2. Segal R, Lubart E, Leibovitz A, Berkovitch M, Habot B, Yaron M, Caspi D. Early and late effects of low-dose aspirin on renal function in elderly patients. Am J Med. 2003 Oct 15; 115(6):462-6.
    View in: PubMed
    Score: 0.042
  3. Pelletier JP, Yaron M, Haraoui B, Cohen P, Nahir MA, Choquette D, Wigler I, Rosner IA, Beaulieu AD. Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. The Diacerein Study Group. Arthritis Rheum. 2000 Oct; 43(10):2339-48.
    View in: PubMed
    Score: 0.034
  4. Caspi D, Lubart E, Graff E, Habot B, Yaron M, Segal R. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum. 2000 Jan; 43(1):103-8.
    View in: PubMed
    Score: 0.033
  5. Tishler M, Brostovski Y, Yaron M. Effect of spa therapy in Tiberias on patients with ankylosing spondylitis. Clin Rheumatol. 1995 Jan; 14(1):21-5.
    View in: PubMed
    Score: 0.023
  6. Segal R, Yaron M, Tartakovsky B. Methotrexate: mechanism of action in rheumatoid arthritis. Semin Arthritis Rheum. 1990 Dec; 20(3):190-200.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)